| ESKD | End-stage kidney disease |
| aSMCs | Arterial smooth muscle cells |
| CKD | Chronic kidney disease |
| DEGs | Differentially expressed genes |
| Log2FC | Log2 fold change |
| FDR | False discovery rate |
| Padj | Adjusted p-value |
| pCut | p-value cutoff |
| ER | Endoplasmic reticulum |
| UPR | Unfolded protein response |
| ERAD | ER-associated degradation |
| ROS | Reactive oxygen species |
| GSH | Reduced glutathione |
| CVD | Cardiovascular diseases |
| VSMCs | Vascular smooth muscle cells |
| NPA | Normal pig serum treated aSMCs |
| UPA | Uremic pig serum treated aSMCs |
| Go | Gene Ontology |
| ORA | Overrepresentation analysis |
| GSEA | Gene set enrichment analysis |
| MF | Molecular function |
| ECM | Extracellular matrix |